This compound is a pharmaceutical intermediate used in the manufacturing of ezetimibe. It features a complex structure with multiple aromatic rings, halogen atoms, and silicon-containing protecting groups, designed for stereoselective synthesis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 272778-12-8
N-(4-(Benzyloxy)benzylidene)-4-fluoroaniline
pharmaceutical intermediate
4-(4-Fluorobenzoyl)butyric acid
pharmaceutical intermediate
Sodium lactobionate
pharmaceutical intermediate
7-amino-1,3,5-naphthalenetrisulfonic acid
pharmaceutical intermediate
Alverine EP Impurity D HCl
pharmaceutical intermediate
N-(4-Amino-6,7-dimethoxyquinazolin-2-yl)-N-methylpropane-1,3-diamine Dihydrochloride
pharmaceutical intermediate
4-((1S,2R)-5-Cyano-5-(4-fluorophenyl)-1-((4-fluorophenyl)amino)-2-((S)-2-oxo-4-phenyloxazolidine-3-carbonyl)-5-((trimethylsilyl)oxy)pentyl)phenyl pivalate
research reagent
(4S)-3-[(2R,5S)-2-[(S)-(4-fluoroanilino)-(4-trimethylsilyloxyphenyl)methyl]-5-(4-fluorophenyl)-5-trimethylsilyloxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one
XXMINDVVBVJXLN-GOFGAPPUSA-N
C[Si](C)(C)OC1=CC=C(C=C1)[C@H]([C@@H](CC[C@@H](C2=CC=C(C=C2)F)O[Si](C)(C)C)C(=O)N3[C@H](COC3=O)C4=CC=CC=C4)NC5=CC=C(C=C5)F